Assertio Holdings (ASRT) Total Non-Current Liabilities (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Total Non-Current Liabilities came in at $130.8 million in Q1 2026, down 22.02% year-on-year from $167.8 million in Q1 2025, and down 21.49% quarter-over-quarter from $166.6 million in Q4 2025.

Assertio Holdings (ASRT) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Total Non-Current Liabilities across 8 years of filings, most recently posting $130.8 million for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $130.8 million, down 22.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $130.8 million (down 22.02% YoY), and the FY2025 annual result was $166.6 million, up 8.56% from the prior year.
  • Total Non-Current Liabilities came in at $130.8 million for Q1 2026 at Assertio Holdings, down from $166.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $205.9 million in Q3 2025 to a low of $128.9 million in Q3 2024.
  • The 5-year median for Total Non-Current Liabilities is $166.6 million (2025), against an average of $160.7 million.
  • Across the five-year window, Total Non-Current Liabilities slumped 32.97% in 2023 and surged 59.72% in 2025, its largest moves.
  • Assertio Holdings' Total Non-Current Liabilities stood at $183.9 million in 2022, then retreated by 28.25% to $132.0 million in 2023, then rose by 16.33% to $153.5 million in 2024, then advanced by 8.56% to $166.6 million in 2025, then declined by 21.49% to $130.8 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $130.8 million (Q1 2026), $166.6 million (Q4 2025), and $205.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn 130.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 130.82 Mn
Dec 31, 2025 166.64 Mn
Sep 30, 2025 205.95 Mn
Jun 30, 2025 171.58 Mn
Mar 31, 2025 167.76 Mn
Dec 31, 2024 153.50 Mn
Sep 30, 2024 128.94 Mn
Jun 30, 2024 130.91 Mn
Mar 31, 2024 131.07 Mn
Dec 31, 2023 131.96 Mn
Sep 30, 2023 187.16 Mn
Jun 30, 2023 145.33 Mn
Mar 31, 2023 137.01 Mn
Dec 31, 2022 183.92 Mn
Sep 30, 2022 184.04 Mn
Jun 30, 2022 170.35 Mn
Mar 31, 2022 204.41 Mn
Dec 31, 2021 219.50 Mn
Sep 30, 2021 171.69 Mn
Jun 30, 2021 214.47 Mn